<?xml version="1.0" encoding="UTF-8"?>
<p>Same as many bacterial and fungal species, antimicrobial resistance is an emerging problem with the 
 <italic>Candida</italic> spp. Centre for Disease Control and Prevention (CDC) reports that, about 7% and 1.6% of all systemic infection causing 
 <italic>Candida</italic> isolates from year 2012-2016 demonstrated a resistance to the first line antifungal drug, fluconazole and to echinocandins.
 <xref rid="B19" ref-type="bibr">
  <sup>19</sup>
 </xref> Hence, new therapeutic options are needed to effectively address the emerging issue of developing antimicrobial resistance, in addition to overcoming the toxicities and drug interactions that are associated with available antifungal agents.
 <sup>20</sup> Plant derived natural therapeutics are becoming more popular among the vast majority of the modern world due to its low toxicity, easy accessibility, cost efficacy as well as the high therapeutic potency.
 <xref rid="B20" ref-type="bibr">
  <sup>20</sup>
 </xref> In this aspect, 
 <italic>Cinnamomum verum</italic>/ True Cinnamon, has been shown to be of great economic and pharmaceutical-medicinal interest.
 <xref rid="B21" ref-type="bibr">
  <sup>21</sup>
 </xref>
</p>
